Overexpression of ABC transporters, frequently detected in human solid and hematologic cancers, is a marker for drug resistance and decreased patient survival[17]; moreover, high levels of ABC transporters can be found also in cancer stem cells[18]. Here, ABCG2 is linked to hematopoietic and lymphoid cell neoplasm.